| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 3.492 | 11.489 | 39.854 | - | 41.729 | 46.790 | 58.880 | - | - |
| Total Income - EUR | - | 3.950 | 11.538 | 39.854 | - | 41.729 | 46.790 | 58.880 | - | - |
| Total Expenses - EUR | - | 5.290 | 6.939 | 24.526 | - | 25.903 | 31.694 | 30.297 | - | - |
| Gross Profit/Loss - EUR | - | -1.340 | 4.599 | 15.328 | - | 15.825 | 15.095 | 28.583 | - | - |
| Net Profit/Loss - EUR | - | -1.445 | 4.253 | 14.132 | - | 14.618 | 13.720 | 27.337 | - | - |
| Employees | - | 0 | 0 | 0 | - | 0 | 0 | 1 | - | - |
Check the financial reports for the company - Rayanmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 33.602 | - | 18.067 | 8.027 | 58.365 | - | - |
| Current Assets | - | 570 | 3.093 | 4.796 | - | 35.554 | 54.230 | 30.737 | - | - |
| Inventories | - | 0 | 0 | 0 | - | 0 | 0 | 1.388 | - | - |
| Receivables | - | 0 | 687 | 0 | - | 4.862 | 22.688 | 18.015 | - | - |
| Cash | - | 570 | 2.406 | 4.796 | - | 30.693 | 31.541 | 11.333 | - | - |
| Shareholders Funds | - | -1.400 | 2.876 | 16.955 | - | 46.607 | 59.293 | 86.814 | - | - |
| Social Capital | - | 45 | 44 | 43 | - | 41 | 40 | 41 | - | - |
| Debts | - | 1.970 | 217 | 21.443 | - | 7.014 | 2.964 | 2.288 | - | - |
| Income in Advance | - | 0 | 0 | 0 | - | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Rayanmed Srl